Cargando…

RF24 | PSUN94 Long-Term Safety of Diazoxide Choline Extended-Release (DCCR) Tablets in Patients with Prader-Willi Syndrome

BACKGROUND: Prader-Willi syndrome (PWS), a rare genetic neurobehavioral-metabolic condition, is characterized by hyperphagia, accumulation of excess fat, hypotonia, and behavioral/psychological complications. There are no currently approved medications to treat hyperphagia in patients with PWS; DCCR...

Descripción completa

Detalles Bibliográficos
Autores principales:	Woloschak, Michael, Miller, Jennifer, Felner, Eric, Bird, Lynne, Angulo, Moris, Mejia-Corletto, Jorge, Gevers, Evelien, Shoemaker, Ashley, Yanovski, Jack, Butler, Merlin, Salehi, Parisa, Stevenson, David, Wilding, John, Abuzzahab, Jennifer, Konczal, Laura, Guftar Shaikh, M, Viskochil, David, Lah, Melissa, Mathew, Verghese, Yen, Kristen, Bhatnagar, Anish, Obrynba, Kathryn
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Adipose Tissue, Appetite, & Obesity
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9624606/ http://dx.doi.org/10.1210/jendso/bvac150.074

Ejemplares similares

OR10-2 Hormonal and Cardiometabolic Changes Associated with Diazoxide Choline Extended-Release (DCCR) Tablets in Patients with Prader-Willi Syndrome
por: Abuzzahab, Jennifer, et al.
Publicado: (2022)

Diazoxide Choline Extended-Release Tablet in People With Prader-Willi Syndrome: A Double-Blind, Placebo-Controlled Trial
por: Miller, Jennifer L, et al.
Publicado: (2023)

PSUN92 Type 1 Diabetes and Obesity: The Overlooked Epidemic
por: Burguera-Couce, Ella, et al.
Publicado: (2022)

PSUN119 Obesity As An Independent Factor In Outcome Of SIADH Hospitalizations
por: Maghari, Ibrahim, et al.
Publicado: (2022)

PSUN100 What Determines Leptin Levels: Moving Beyond Fat Mass
por: Rosenberg, Drake, et al.
Publicado: (2022)

RF24 | PSUN95 Defining Predictors of Weight Loss Response to Lorcaserin
por: Gugger, Aristea Sideri, et al.
Publicado: (2022)

RF12 | PSUN105 Cord Blood Leptin and Childhood Adiposity Outcomes in the Hyperglycemia and Adverse Pregnancy Outcome Follow-up Study
por: DeLacey, Sean, et al.
Publicado: (2022)

RF12 | PSUN125 Lymphoma in Congenital Leptin Deficiency: Comorbidity or Adverse Effect?
por: Torchen, Laura, et al.
Publicado: (2022)

RF24 | PSUN127 Congenital Leptin Deficiency: Metabolic, Reproductive, and Psychological Impacts of Therapy
por: Torchen, Laura, et al.
Publicado: (2022)

PSUN112 Expression of Vitamin D Receptor Pathway Genes Across Tissues of Individuals with Obesity
por: Sisley, Stephanie, et al.
Publicado: (2022)

PSUN83 Exploring the Role of PARP1-mediated ADP-ribosylation in Diet-induced Obesity
por: Lee Kraus, W, et al.
Publicado: (2022)

MON-095 Phentermine Induces Weight Loss in Prader-Willi Syndrome
por: Mottalib, Adham, et al.
Publicado: (2019)

RF12 | PSUN103 Wireless Mobile Device Overuse and Obesity: Understanding the Neuroscience, Implications and Interventions
por: Gupta, Nidhi
Publicado: (2022)

PSUN82 The Gut Microbiome Regulates Healthy Adipose Tissue Expansion via the Action of FFA2
por: Nnyamah, Christine, et al.
Publicado: (2022)

RF12 | PSUN80 A Novel DXA Algorithm to Aid in the Diagnosis of Familial Partial Lipodystrophy
por: Harris, Charles, et al.
Publicado: (2022)

RF12 | PSUN118 Diet Quality and Energy Intake Mediate the Association of Food Insecurity with Adiposity
por: Morselli, Lisa, et al.
Publicado: (2022)

FRI082 Impact Of Setmelanotide On Metabolic Parameters And Vital Signs In Patients With Hypothalamic Obesity
por: Jennifer Abuzzahab, M, et al.
Publicado: (2023)

FRI066 Treatment History And Comorbidities Reported By Patients With Hypothalamic Obesity Treated With Setmelanotide In A Phase 2 Trial
por: Roth, Christian L, et al.
Publicado: (2023)

SAT656 Weight Reduction After 6 Months Of Setmelanotide Treatment In Patients With Hypothalamic Obesity
por: Roth, Christian L, et al.
Publicado: (2023)

RF12 | PSUN104 Visceral adiposity index as a measure of cardiometabolic disease in persons living with HIV
por: Thomas, Teressa Sumy, et al.
Publicado: (2022)

PSUN120 Hepatic Fibrosis and Race/Ethnicity in Adult US Population: Data from NHANES 2017-18
por: Puri, Vishwajeet, et al.
Publicado: (2022)

PSUN121 Nonalcoholic Steatohepatitis (NASH), Race/Ethnicity, and Gender in Adult US Population of NHANES 17-18
por: Friedman, Theodore, et al.
Publicado: (2022)

RF36 | PSUN93 A Role for Somatostatin in Regulating Weight Regain after Bariatric Surgery in Mice
por: Arad, Yhara, et al.
Publicado: (2022)

RF36 | PSUN101 Liver and Adipose Tissue Effects of Triiodothyronine Treatment in an Animal Model of Metabolic Syndrome
por: Canha, Marta Borges, et al.
Publicado: (2022)

RF28 | PSUN198 The Dramatic Fat Mass Loss Caused by Bimagrumab is Similar in Diabetic and Non-diabetic Patients.
por: Klickstein, Lloyd, et al.
Publicado: (2022)

PSUN97 Regulation of melanocortin-3 and -4 receptors by isoforms of melanocortin-2 receptor accessory protein 1 and 2
por: Ji, Ren-Lei, et al.
Publicado: (2022)

SUN-597 Healthcare Utilization Patterns Among Commercially Insured Patients with Prader-Willi Syndrome: A Retrospective Analysis of Administrative Claims
por: Butler, Merlin G, et al.
Publicado: (2020)

PSUN113 Evaluating The Efficacy Of Anti-Obesity Medications In a Multidisciplinary Weight Management Clinic At a VA Medical Center
por: Goettemoeller, Travis, et al.
Publicado: (2022)

FRI065 Trial Design Of A Double-blind, Randomized, Placebo-controlled, Phase 3 Study Of Setmelanotide In Patients With Hypothalamic Obesity
por: Roth, Christian L, et al.
Publicado: (2023)

PSUN114 Correlation of Percent Body Fat From Two-Electrode Bioelectric Impedance Analysis and Dual-Energy X-Ray Absorptiometry
por: Roongjiraroj, Thanasate, et al.
Publicado: (2022)

PSUN123 Increased Expression of Insulin Signaling Intermediates After Six-Months Of Medical Care In Women With Obesity And Polycystic Ovary Syndrome
por: Akalestou, Elina, et al.
Publicado: (2022)

RF36 | PSUN79 Prolonged Stimulation of β-Adrenergic Receptors in Human Brown and White Adipocytes Increases and then Decreases Metabolic Activity
por: Katz, Jacqueline M, et al.
Publicado: (2022)

MON-093 Myokine Levels after Resistance Exercise in Young Adults with Prader-Willi Syndrome (PWS)
por: Hirsch, Harry, et al.
Publicado: (2019)

PSUN84 Chronic Adrenergic Stimulation in Humans Increases Plasma Bile Acids and Expression of Bile Acid Synthesis Enzymes in White Adipose Tissue
por: Zhu, Alexander R, et al.
Publicado: (2022)

SUN-604 U.S. Prevalence & Mortality of Prader-Willi Syndrome: A Population-Based Study of Medical Claims
por: McCandless, Shawn E, et al.
Publicado: (2020)

RF24 | PSUN108 Inpatient and Readmission Outcomes Following Endoscopic Gastrectomy Versus Gastrojejunostomy in Patients with Morbid Obesity: A Nationwide Retrospective Analysis
por: Abusalim, Abdul-rahman, et al.
Publicado: (2022)

SUN-595 Comparative Comorbidity Burden Among Patients with Prader-Willi Syndrome: A Population-Level Cohort Study
por: Stafford, Diane E J, et al.
Publicado: (2020)

PSUN81 A novel case of congenital generalized lipodystrophy (CGL) with no genetic abnormalites in the AGPAT2, BSCL2, CAV1, and CAVIN1 genes.
por: Mericq, Veronica, et al.
Publicado: (2022)

RF12 | PSUN106 Quantifying Liver and Brain Levels of 11β-hydroxysteroid Dehydrogenase Type 1 in Obesity Using Positron Emission Tomography Imaging
por: Bini, Jason, et al.
Publicado: (2022)

SUN-608 Juvenile Toxicity Study of Livoletide: A Peptide Analogue of Unacylated Ghrelin for the Treatment of Hyperphagia in Prader-Willi Syndrome
por: Xu, Howard, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_mhrqcc4dsodj1c702tcokq1dfi